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Abstract 
	 Premature birth is a global problem, affecting both developed and undeveloped countries 
including the United States.	A	crucial	aspect	of	both	preterm	and	term	birth	is remodeling of the 
cervix. Despite the large scale of the problem, factors leading to the initiation of remodeling are 
largely unknown. The present study examined the role of the cholinergic anti-inflammatory 
pathway, with particular focus on the nicotinic receptor, and its role in driving remodeling and 
preterm birth. Mice were treated with either vehicle control, mecamylamine (a nonspecific 
nicotinic receptor antagonist), RU486 (a progesterone receptor antagonist) as a preterm control, 
or progesterone (a hormone involved in the timing of birth) as a delayed birth control, using an 
novel thermogel treatment delivery method (TIM). Animals were sacrificed post partum and 
their cervixes were stained to analyze cell nuclei density and macrophage content, two factors 
expected to change during remodeling and parturition. Though the TIM was effective in 
delivering the drug treatments, mecamylamine did not cause preterm birth or a change in 
macrophage content and cell nuclei density. The results of this experiment indicate that the 
nicotinic receptor does not play a role in driving remodeling or preterm birth. Though the 
treatment did not yield significant results, the effectiveness of the TIM means that it may be 
developed into the first minimally invasive direct to cervix treatment in humans.   
Introduction 
	 Preterm birth is an all too common occurrence in the United States. In 2012, 1 in 9 babies 
was born prematurely (March of Dimes et al. 2012). Globally the U.S. ranks 131st out of 184 
countries in the number of babies born prematurely, with significantly higher amounts of preterm 
birth than other developed nations (Hellwig 2012). Babies born prematurely, defined as before 
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the 37th week of pregnancy, are at significantly higher risk for respiratory distress, cerebral palsy, 
vision and hearing problems, and developmental delay, with symptoms becoming more severe 
the earlier the birth (World Health Organization 1970; Institute of Medicine 2007). Because of 
this, preterm babies are also more likely to die within their first 28 days (neonatal period) as well 
as first year than those born at term (Institute of Medicine 2007). The shortened development 
time affects a broad range of biological systems, but especially the lungs and respiratory system. 
It is not uncommon for babies born before 33 weeks to experience respiratory distress syndrome, 
and those born before 30 weeks to lack alveoli entirely, and thus experience significantly 
hindered breathing, and often develop chronic lung disease that is associated with growth, health, 
and neurodevelopmental problems (Institute of Medicine 2007). Additionally, because of the 
immediate severity of early birth, the majority of these babies must be admitted to neonatal care 
at great emotional and financial cost to the family. The financial burden of staying in the NICU 
for extended periods of time can often surpass $50,000, well outside the realm of feasibility for 
low income families or those with poor insurance (Institute of Medicine 2007). Babies that 
manage to survive past their stay in NICU are still at an increased risk for developmental issues 
later in life such as special educational requirements as well as fine motor skill development 
problems (Mackay et al. 2010; Hutton et al. 1997). In fact, special education needs (SEN) have 
been inversely correlated with gestation time, such that shorter gestation shows an increased 
proportion of SEN (Mackay et al. 2010). Critically, many adolescents and young adults who 
were born preterm continually demonstrate decreased cognitive ability compared those born at 
term (Institute of Medicine 2007).  
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 Despite the large scale of the issue, the cause of preterm birth is not well understood. 
Often this process occurs spontaneously, however it is also possible for it to be caused by 
infection or early rupture of the fetal membranes (Timmons et al. 2010). Still some risk factors 
have been identified. Smoking for example is often cited as a cause of ectopic pregnancy, low 
birth weight, and increased infant mortality, but it has also been implicated in preterm birth 
(Office of the Surgeon General et al. 2004). Other studies have identified multiple births as well 
as short time between births (interpregnancy intervals) as possibly playing a significant role in 
increasing a woman’s chances of delivering early (DeFranco 2007).  
 Still, knowledge in this field is rapidly developing, and several studies have shown 
promising leads regarding certain biomarkers as predictors of preterm birth risk. A biomarker is 
simply a measurable substance that is indicative of a phenomenon. It may cause the phenomenon 
or simply be present in elevated levels during the event. Several proinflammatory and anti-
inflammatory cytokines known as interleukins (IL) have been implicated as possible biomarkers. 
Molecules such as interleukin-10 have been examined as early indicators of preterm labor 
(Dubicke et al. 2010).  Separately it has proven difficult to isolate biomarkers which can be 
solely indicative of preterm labor due to both the vast amount of potential biomarkers as well as 
variability in the expression of these factors (Holt et al. 2011). However, researchers have 
preformed analytics such as multifactor dimensionality reduction analysis on biomarkers found 
in tissues varying from maternal plasma and cord plasma to amniotic fluid in order to examine if 
the ratios of various molecules are better biomarkers than individual substances (Bhat et al. 
2014). Through this analysis researchers determined that elevated levels of angiopoietin 2 and 
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tumor necrosis factor alpha (TNFα) can be used as possible predictors of preterm birth (Bhat, et 
al. 2014).   
 Additionally, researchers have proposed a correlation between the length of the cervix 
and risk for preterm birth. It seems that women whose cervixes are shorter run a higher risk of 
preterm birth than women with average cervix lengths (Feltovich et al. 2012). Though a clear 
and noticeable predictor for preterm birth has yet to be found, this development supports the 
concept that the cervix acts as an important barrier during pregnancy, possibly serving as a 
gatekeeper between the developing baby and the outside environment. This serves to both keep 
the baby safely developing in the uterus and prevents foreign bodies from reaching the baby. 
 There are two major organ structures involved in pregnancy and parturition, the uterus 
and the cervix. Though anatomically these may seem just separate regions of the same 
abdominal pelvic organ, they play vastly different roles throughout pregnancy. The baby 
develops in the uterus, which is composed of smooth muscle. This smooth muscle produces the 
contractions responsible for pushing the baby out in the final stage of parturition (Myers et al. 
2015).  The cervix is the structurally rigid, lower distal portion of the uterus consisting of the 
opening to the vagina, called the os (Myers et al. 2015; Timmons et al. 2010). In typical 
pregnancy the cervix acts as a protective barrier for both the baby and the uterine environment 
until parturition, remaining rigidly closed and sealed by a mucous plug (Feltovich, et al. 2015). 
Its rigidity is due largely to the dense extracellular collagen matrix that makes up the cervix, 
allowing it to withstand the pressure of the fetus developing in the uterus. At the time of 
parturition the cervix undergoes a remodeling process including a massive reorganization of its 
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collagen matrix, ultimately allowing for the passage and birth of the mature fetus (Uldbjerg, et 
al. 1983). 
  Ultimately the cervix and the uterus both respond to various signals to coordinate the 
timing of birth. One of the most studied signals is the hormone progesterone. In both human and 
mouse models, progesterone serves to maintain pregnancy. However, towards the end of 
pregnancy, the human cervix and uterus undergo progesterone withdrawal whereby receptors are 
unable to respond to the hormone. This prevents the pregnancy from continuing and begins 
parturition (Parizek et al. 2013; Zakar et al. 2007). Though many researchers focus on the uterus, 
every case of preterm birth is accompanied by premature cervical remodeling (Timmons et al. 
2010). It is simply impossible for the baby to pass without remodeling the cervix and as such, 
this process merits more intense study (Word et al. 2007).  
 Remodeling of the cervix is not a singular event, but rather a process that occurs 
throughout pregnancy, which culminates in the dilation of the cervix and passage of the baby 
(Fig. 1; Word et al. 2007). Additionally, some researchers believe that due to apoptotic events 
early in pregnancy, the process of remodeling may be initiated as early as conception (Leppert 
1998).  Remodeling appears as an inflammatory response occurring in three major steps: 
softening, ripening, and dilation  (Fig. 1) (Norman, et al. 2007; Christiaens, et al. 2008; 
Bollopragada et al. 2008).  
Barrero 7 
   
 
  
 Softening is the longest stage of remodeling, which can occur until the 32nd week of 
pregnancy (fig. 1). This stage is marked by swelling and hypertrophy as well as increased 
vascularity. This stage is also marked by innervation. During innervation, the amount of nerve 
fibers in the cervix is maintained and even increases. This change is unique to the cervix, as 
studies have shown that the uterus can lose nerve fibers during pregnancy (Tingåker et al. 2006). 
The major nerves that innervate the cervix and uterus during pregnancy are the parasympathetic 
fibers of both the pelvic and the vagus nerve (Clyde et al. 2010). These nerve fibers are crucial 
for both maintaining pregnancy as well as initiating the birthing process by controlling the 
release of either pro-inflammatory or anti-inflammatory cytokines, which become increasingly 
important in a later stage (Dubike et al. 2009; Collins et al. 2002).  
Figure 1. The remodeling process of the cervix and corresponding biological 
factors during major stages. (Word et al. 2007) 
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 Softening is followed by ripening, typically occurring between weeks 32 and 37 (fig. 1). 
This stage is marked by changes in the collagen rich extracellular matrix of the cervix along with 
an increase in hyaluronic acid (HA) and glucosaminoclycans (GAGs). This in turn decreases the 
structural integrity of the cervix, increasing distensibility (Word et al. 2007).   
 The final stage of remodeling is dilation (fig. 1). Typically occurring from the 37th week 
until birth, this is the shortest stage and accounts for the greatest increase in distensibility. 
Though immune cells are present throughout remodeling, there is a massive infiltration by 
leukocytes during dilation. Both the release of proinflammatory cytokines and the withdrawal of 
anti-inflammatory cytokines signal immune cells, particularly  macrophages, to migrate into the 
cervix. This migration of macrophages and other immune cells leads to increased hypertrophy of 
cervical tissue through the propagation of inflammatory cytokines and the release of various 
chemicals that weaken the structure of the cervix (Hamilton et al. 2012). Finally comes 
degradation and reorganization of collagen fibers in the cervix brought on mainly by the release 
of collagenase and nitric oxide synthase (NOS) from the macrophages. This process decreases 
the tensile strength of the cervix, allowing it to dilate. Additionally, hormonal signals throughout 
the remodeling process are crucial. As already briefly mentioned, progesterone is a hormone 
known to play a significant role in the maintenance of pregnancy. At a certain point during late 
pregnancy, its receptors under an isoform switching. This results in the coding and production of 
a slightly structurally different progesterone receptor that cannot bind progesterone, and in turn 
makes maintaining the pregnancy impossible, initiating the labor process (Parizek et al. 2013). 
Thus, though serum progesterone does not dip like in the mouse model, a similar affect is 
achieved. The process of remodeling occurs to some degree through the entirety of the 
Barrero 9 
pregnancy; though its most dramatic changes occur typically during dilation in week 32, 
consisting of an extreme increase in cervical distensibility brought on by immune cell migration, 
NOS production, and reduced collagen concentration (fig. 1). 
  
 
 
  
 
 
 A clear illustration of how this immune infiltration progresses is demonstrated in figure 
2. Increasing hypertrophy is shown by the apparent decrease in cell nuclei density between the 
non-pregnant and pregnant animals. Additionally there is a clear increase in macrophages present 
in post breeding day 18 compared to both day 15 and non-pregnancy, demonstrating the 
Figure 2. Rat cervixes samples taken at different days of gestation stained with methyl blue for 
cell nuclei and F4/80 for macrophages. NP= non pregnant; d15 & d18= post breeding days 15 
and 18 respectively; PP=post partum. Black arrows point to cell nuclei, red arrows point to 
macrophages Scale bar represents 100 µm. 
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macrophage infiltration which is key to the remodeling of the cervix. Mice are expected to give 
birth on day 19 of pregnancy, and as such day 15 and 18 are when cervical remodeling and 
dilation occur respectively. Figure 2 demonstrates that on those days, immune cell migration 
increases along with hypertrophy of other cells, shown by decreased apparent cell density. 
 
 Currently there are no effective treatments for preterm birth. While uterine contractions 
can be paused using treatments such as tocolytic prophylaxis, it only stalls birth for a short 
period of time (hours) when the baby would need weeks to fully develop (Simhan et al. 2007). 
Unfortunately, despite being a common treatment it seems that tocolytics alone seem to have no 
significant benefit to the baby, and when used in combination with steroids to mature the 
respiratory system has only minimally beneficial effects (Berkman et al. 2003). The core issue 
remains that once the remodeling process has been triggered, there is no way to stop parturition. 
For that reason an emphasis on preventative treatments is crucial. By understanding the 
processes that govern the initiation of parturition and remodeling, the door is opened for 
development of treatments that could prevent these processes, leading to more effective 
treatments with reduced impact on both short and long term well-being of the child.  
 This study uses mice as a model organism for parturition. Mice are consistently and 
widely accepted as animal models for preterm birth as they go through similar changes in 
cervical collagen content, cell nuclei density, and macrophage presence during cervical 
remodeling, as well as have similar hormonal regulation, the major difference being that in mice 
a drop in serum progesterone takes the place of a receptor isoform switch (Mitchell et al. 2009). 
For this reason, progesterone is able to induce delayed birth in mice. Additionally mice have a 
short 19 day gestation period and are relatively simple to care for.  
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 With this in mind, this study asks the question: Do particular nerve pathways or 
neurotransmitters play a critical role in signaling the remodeling process? In order to begin to 
answer that question, this study examines neural regulation of immune function in the cervix 
through the vagus nerve, particularly focusing on the role of the neurotransmitter acetylcholine 
through the cholinergic anti-inflammatory pathway in the timing of birth, recruitment and 
activation of immune cells, as well as the remodeling process, which along with innervation of 
the cervix are crucial aspects of preterm and term birth (Yellon et al. 2003; Kirby et al. 2005). 
 Acetylcholine is the main neurotransmitter in the cholinergic anti-inflammatory pathway 
(Rosas-Ballina et al. 2009), which inhibits immune cell migration and cytokine production, two 
crucial factors for the remodeling process (Collins et al. 2002; Winkler 2003). Nicotinic 
cholinergic receptors bind to acetylcholine from the vagus nerve, and initiate the Jak2-STAT3 
signaling pathway. Through this pathway, transcription factor STAT3 binds and activates DNA, 
which codes for anti-inflammatory cytokines such as interleukin 10 (IL-10) (de Jonge et al. 
2005). Because acetylcholine can act on macrophages through several groups of receptors, this 
study focuses specifically on nicotinic receptors. In other regions of the body nicotinic receptors 
have been shown to have a key role in ameliorating inflammation (Nemethova et al. 2013).  
Mecamylamine was used to perform a chemical neurectomy, delivered by novel treatment 
delivery method directly to the cervix. Treatments were achieved through the development of a 
injectable transport media (TIM) formulated from Pluronic F-127 thermogel and agar, loaded 
with drug treatment and injected directly into the vaginal canal. This transport media was found 
to be biologically inert and effective in pilot studies for this experiment. Mecamylamine is a 
nonspecific antagonist for the nicotinic receptors of the cholinergic pathway, and as such it’s 
binding should prevent the Jak2-STAT3 pathway from propagating. As a result, the typical anti-
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inflammatory effects are predicted be absent in treated mice. This would demonstrate if this 
pathway is crucial for remodeling of the cervix (Nemethova et al. 2013).  
 It is expected that blocking of the anti-inflammatory pathway would promote 
macrophage infiltration, encouraging remodeling of the cervix and ultimately preterm birth. 
Thus, treatment with mecamylamine can be used to understand the role of acetylcholine and the 
nicotinic receptor in the remodeling of the cervix. In addition to providing a better understanding 
of crucial innervation during pregnancy, this study could provide groundwork for the first 
method to effectively treat preterm birth. If crucial neurotransmitter pathways are identified to 
cause preterm birth, antagonists for these pathways can be theoretically given to human patients. 
This would effectively be the first treatment to prevent the crucial step of remodeling of the 
cervix instead of just blocking contractions. By tackling an earlier stage in parturition, treatments 
as proposed by this study have the potential to effectively delay birth until the baby is fully 
developed by maintaining the structural integrity of the cervix for a much longer period of time. 
Conversely, in the event that birth needs to be medically induced, an agonist to this pathway 
could be used as a treatment. This would remove the need for cesarean section surgeries and the 
inherent risks that come with them. 
	
 
 
 
 
Methods 
Animals	
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 CD-1 non-transgenic mice were used. Mice were ordered as day 13 post-breeding and 
allowed to acclimatize for one day. Treatment started on post breeding day 14 (D14).  All 
animals were humanly treated according to IACUC protocol. 
Formulation of Transport Implantable Media 
 In order to effectively deliver drugs to the cervix, a novel method of delivery was 
required. An implantable transport media (TIM) was developed by combining the thermogel 
Pluronic F-127 (Sigma Aldrich) and the thickening agent agar (25% & 2% w/v respectively). PF-
127 is a thermogel which is solid at 37˚ C, the body temperature of mice, yet remains liquid at 
room temperature, facilitating the dissolution of treatments into the media. It is biologically inert 
and has been used previously as a drug delivery system in other regions of the body with 
successful results (El-Kamel 2002; Das et al. 2010). Agar was used to increase structural 
rigidity. Solutions of PF-127 were created in water as per instruction by the manufacturer, 
making sure to mix slowly and on ice until completely dissolved. These solutions were mixed 
with cooling agar to the desired final concentrations. Doses of each treatment were measured and 
mixed in to batches of the TIM such that a 0.9 mL volume would contain a single dose. These 
treatment or control loaded TIMs were drawn into a modified syringe for use on treatment days. 
Drug loaded TIM batches were formulated as close to the date of treatment as possible and 
inspected before use to ensure the drug remained in solution. Pilot studies were performed using 
DiD fluorescent dye loaded TIM in non-pregnant mice in order to visually assess diffusion into 
the cervix (fig. 3). 
 Treatment of Mice 
Barrero 14 
 Mice were divided into 4 groups. One group received the experimental treatment 
mecamylamine (n=3), an antagonist to the nicotinic receptor  of the cholinergic anti-
inflammatory pathway, at one half of the LD50 dosage (15mg/kg; Aceto et al. 1969; Young et al. 
2001). The remaining mice were divided into several controls. RU486 (150 µg; n=4), a 
progesterone receptor antagonist, was used as an early birth control because it consistently and 
reliably induces birth within 24 hours of treatment. Progesterone (1mg; n=4) was used as a 
delayed birth control, as mice treated with progesterone typically give birth a day late. Finally, 
vehicle controls (n=3) received no drug and served to make sure the TIM was having no effect 
and provide an example of term pregnancy for comparison.	
 
  
 
Treatment consisted of injections every two days over the course of the experiment (D14 and 
Figure 3. Photomicrographs of DiD fluorescent dye and vehicle control TIM treated mice 
transitioning from the cervix-lumen interface to the uterus transition. DiD fluoresces red 
(665nm) and is highlighted by yellow circles.  
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D16 post breeding). Immediately prior to treatment mice were fixed with surgical collars in 
order to prevent vaginal grooming. To preform the treatments TIMs were drawn into a modified 
syringe and 0.9mL (one dose) of solution was injected through vaginal canal in order  to ensure 
contact of TIM with the cervix. After each treatment animals were observed for two hours to 
monitor their well-being. 
 
 
Analysis 
Figure 4: Biopsy of the cervix stained for cell nuclei and macrophages by methyl blue and 
F4/80 respectively. Green boxes represent 417x300 µm photomicrographs (8 total) taken for 
analysis. Scale bar represents 3 mm. 
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Mice were sacrificed post partum by CO2 asphyxiation. Animals were externally examined for 
blood on the vaginal pore, an indication of difficult birth. Implantations sites in the uterine horns 
were counted and recorded, as well as the amount of pups present in the cage at time of sacrifice.  
 
 
 
Pups were checked for viability after birth. Cervix and uterine tissues excised from mice were  
 
 
Veh P4 
RU486 Mec 
	
	 	
	
	
	
	
	
Figure 5. Photomicrographs of post partum mice stained with methyl blue for cell nuclei and F4/80 
for macrophages. Red arrows indicate example macrophages, black arrows indicate example non 
macrophage cell nuclei (Veh=vehicle; P4=progesterone; RU486=RU486; Mec=mecamylamine). 
Scale bar represents 100µm. 
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placed in paraformaldehyde immediately after collection and transferred to 70% ethanol after 24 
hours. Both tissues were processed for immunohistochemistry including macrophage and cell 
nuclei staining (fig 4; fig. 5) 
 
 Tissues were stained for cell nuclei using methyl blue and macrophages using F4/80, both 
general stains (fig. 5) Scans of the tissues were taken and snapshots of the cervix were taken 
using Aperio ScanScope (2 sets per animal, 8 snapshots per snap). An example of a tissue scan 
and snapshot sites can be seen in figure 4. Cell nuclei and macrophages were counted using the 
cell counter plug-in through the ImageJ program available through the National Institute of 
Health website (http://rsbweb.nih.gov/ij/plugins/cell-counter.html).  Data collected were analyzed 
using 1-way ANOVA and post hoc Dunnett’s tests. All statistics were performed using the 
GraphPad Prism statistical package.  
 
Results 
  
 In the pilot study, fluorescent microscopy of DiD loaded transport injectable media 
(TIM) treated mice (n=3) showed fluorescence in the cervix-lumen interface and the cervix itself, 
but not the cervix-uterus transition (fig 5). Additionally, the vehicle control TIM control group 
(n=3) showed no fluorescence.	 
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 In order to further determine the efficacy of the novel TIM, as well as overall treatment 
effects, day of delivery was compared between the vehicle and all other treatments. As figure 6 
demonstrates, the day of birth for RU486 treated animals was significantly different from the 
vehicle treatment group (p=0.004). No other group significantly differed from the vehicle control 
day of birth as indicated by a Dunnett’s post hoc test. 
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Figure 6. Average day of delivery for mice. Bars represent standard error 
of the mean. Veh=vehicle (n=3); RU486=RU486 (n=4); P4=progesterone 
(n=4); Mec=mecamylamine (n=3). Stars indicate significant difference 
from all other groups  shown by 1way ANOVA and from vehicle controls 
by post hoc Dunnett’s tests (*p=0.004).  
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  No treatment group showed any significant difference in cell nuclei density, as 
demonstrated in figure 7. Macrophage counts, recorded as macrophages per cell nuclei per area, 
demonstrated a slight trend, though it failed to reach significance (p=0.3821). As shown in figure 
8, the progesterone group had a seemingly lower macrophage count post partum compared to all 
other groups. However, despite the apparent trend, no group stood out as significant when 
compared to the vehicle control.  
	
	
	
	
	
	
Figure 7. Average cell nuclei per square micrometer. Error bars represent standard error of 
the mean. 1-way ANOVA  revealed no significant differences. Veh=vehicle (n=2); 
RU486=RU486 (n=2); P4=progesterone (n=4); Mec=mecamylamine (n=2).  
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Discussion: 
 The results of this study seem to indicate that the nicotinic receptor is not significantly 
involved in preterm birth. This conclusion is drawn from the fact that treatment with 
mecamylamine, an antagonist to this receptor, failed to have any clear effect on the timing of 
birth, resulting in mecamylamine treated animals giving birth on average at the same time as 
vehicle controls (fig. 6). On a cellular level, there is no clear effect on the composition of the 
cervix caused by the blocking of this receptor. Cell nuclei and macrophage counts in 
mecamylamine treated animals did not differ significantly from those in vehicle controls, 
indicating that it is essentially the same as term birth (fig. 7; fig. 8).  
 Though the results do not indicate that mecamylamine had any effect on the remodeling 
of the cervix, this is not due to an ineffective drug delivery method. Pilot studies using 
fluorescent dye demonstrated that the TIM could deliver chemicals of similar weight and charge 
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Figure 8. Average macrophages per cell nuclei per square micrometer. Error bars 
represent standard error of the mean. 1-way ANOVA and post hoc Dunnett’s tests 
revealed no significant differences. Veh=vehicle (n=2); RU486=RU486 (n=2); 
P4=progesterone (n=4); Mec=mecamylamine (n=2).  
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into the cervix (fig. 5). Additionally, RU486 animals delivered preterm.  RU486, also known as 
mifepristone, consistently induces birth within 24 hours of treatment (Dudley et al. 1996). For 
this reason it is used within the lab as an indicator of effective drug delivery. In this case the 
RU486 group delivered within 24 hours of treatment and significantly earlier than the vehicle 
control group, supporting the conclusion that the TIM was an effective method of delivery. 
Additionally, the trend toward reduced macrophage presence in the cervixes of progesterone 
treated mice compared with the uterus suggests that treatment was localized to the cervix, not 
affecting the uterus corpus, though further analysis could be performed to confirm this in future 
experiments. This is greatly significant because to the knowledge of this lab, there has never 
been an effective method of delivering drugs directly to the cervix in a minimally invasive 
fashion. Further testing using TIM as a starting point could serve to develop the first direct to 
cervix treatment method for humans. Vaginal treatments could be minimally invasive and simple 
to perform, and represents a huge potential for safe, effective cervix treatment, including both 
postponing and inducing birth.  
 The lack of significant difference in macrophages between mecamylamine and vehicle 
treatment groups indicates that the nicotinic receptor does not play a role in macrophage 
infiltration. Therefore it can be concluded that it is not significant in the initiation of remodeling 
and therefore preterm birth. However, the results may not be as clear as they appear. The biggest 
drawback of this study was the lack of animals. Though a minimum number of 3 animals was 
used per treatment, time constraints made it impossible to take macrophage and cell nuclei 
counts for all of them, dropping the amount of animals in all groups except progesterone (n=2 for 
all). This could have significantly contributed to the lack of significant differences in the cellular 
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analysis of the different groups. Even with the original group sizes, there was a surprising 
amount of variability, including a progesterone treated mouse giving birth significantly preterm 
(D15). This is unexpected and there is no clear explanation. Currently, the lab is exploring if 
stress caused by wearing grooming preventing collars could have contributed to this result. Mice 
groom themselves often and the inability to do so could have caused a stress response in this 
mouse that affected its day of delivery. However, this is unlikely, due to no other mice having 
such a drastic response. Replication with larger groups of animals is necessary to reduce the 
variability within this experiment and clarify if any trends may be significant.  
 Though mecamylamine dosages were based on treatments by other studies, this is the 
first time it has been delivered by thermogel directly into the cervix through the vagina (Aceto et 
al. 1969; Young et al. 2001). It is possible that to see significant effects, the dosages must be 
refined in further experiments. Studies indicate that several nicotinic receptors such as 
α4β2nAchR play an important role in macrophage attenuation in the mouse gut (Nemethova et 
al. 2013; van der Zanden et al. 2009). As such it would be a logical next step to replicate this 
experiment with increased sample sizes and a variety of mecamylamine dosages to ensure that 
the lack of effect is not due to inappropriate dosage levels. However, operating under the 
assumption that the dosages were appropriate, nicotinic receptors can be considered unimportant 
for remodeling of the cervix.  
 Additionally, previous experiments within the lab have attempted to examine the role of 
the second main category of cholinergic anti-inflammatory receptor, the muscarinic receptor. 
However, the lack of an effective delivery method made it impossible to gather clear results. 
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Using TIM it is possible to retry this experiment and possibly eliminate both cholinergic 
receptors as important for remodeling.   
 Besides cholinergic, there are several other receptors have been noted as possible targets 
for future experiments. Several studies have indicated that nociceptors such the vanilloid 
receptor TRPV1 play a role in macrophage driven inflammation (Okada et al. 2011). In the case 
of this particular receptor, studies have also shown that TRPV1 nerve fibers exist in the cervix, 
but disappear from the uterus during pregnancy, suggesting it might play an important role in 
remodeling (Tingåker et al. 2008). This could be studied in much the same way that the nicotinic 
receptor was studied: by employing a drug which agonizes or antagonizes it and examining the 
subsequent effects on the timing of birth as well as cell nuclei density and macrophage 
infiltration. Because the TIM was effective, the methodology of this experiment can be repeated 
using different drug treatments in order to systematically eliminate receptors and neurological 
pathways until one that has a direct effect on preterm birth is found.  
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